---
$id: https://graph.org.ai/products/commodity/51151636
$type: Product
source: UNSPSC
code: "51151636"
title: "Edrophonium chloride"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Edrophonium chloride

**UNSPSC Code**: 51151636
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an acetylcholinesterase inhibitor with the molecular formula C10H16NO.Cl, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QO611KSM5P, chemically known as benzenaminium, n-ethyl-3-hydroxy-n,n-dimethyl- but generally known as edrophonium chloride, which bears US NIH Compound Identifier 3202. European Medicines Agency schedules Edrophonium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06461MIG. The term EDROPHONIUM CHLORIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). Most nations schedule edrophonium chloride under HS 29239000 and SITC 51481. As of Q4 2014, EDROPHONIUM CHLORIDE remains the US FDA Preferred Term for this commodity. Edrophonium chloride bears US NLM identifiers UMLS ID C0013617 and NCI Concept Code C47507. SMILES: CC[N+](C)(C)C1=CC(=CC=C1)O.[CL-].

